Table.1: Potential drug-drug interactions between medications commonly prescribed for cystic fibrosis exacerbation and cardiac medications.¹¹ The potentially hazardous effect, recommended management strategy and drug-drug interaction severity are listed. Regarding severity, ‘+’ is mild, ‘++’ is moderate, ‘+++’ is severe and ‘U’ is unknown.